Victor Ferrans is a Psychiatry physician affiliated with National Institutes of Health. OpenAlex indexes 7 publications with 778 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2324 W Joppa Rd
Suite 220
Lutherville, MD 210934615
Telephone
410-583-2623Registry record last updated 8 Jul 2007.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year202211 payments
- Supernus Pharmaceuticals, Inc.Program year20221 payment
- Takeda Pharmaceuticals U.S.A., Inc.Program year202123 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI26.8%Escitalopram Oxalate36%Sertraline Hcl22%Trazodone Hcl21%Fluoxetine Hcl13%Prozac8%Part D<11 patientsBenzodiazepine12.9%Clonazepam49%Diazepam22%Alprazolam15%Alprazolam Er15%Part D<11 patients+ 10 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Endothelial progenitor cells as putative targets for angiostatin.
PubMed
1999 - Apoptosis and DNA Fragmentation in the Bulbus Cordis of the Developing Rat Heart
Journal of Molecular and Cellular Cardiology
1996
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”